Endothelial Thioredoxin-Interacting Protein Depletion Reduces Hemorrhagic Transformation in Hyperglycemic Mice after Embolic Stroke and Thrombolytic Therapy

We hypothesize that endothelial-specific thioredoxin-interacting protein knock-out (EC-TXNIP KO) mice will be more resistant to the neurovascular damage (hemorrhagic-transformation-HT) associated with hyperglycemia (HG) in embolic stroke. Adult-male EC-TXNIP KO and wild-type (WT) littermate mice wer...

Full description

Bibliographic Details
Main Authors: Mohd. Salman, Saifudeen Ismael, Lexiao Li, Heba A. Ahmed, Michelle A. Puchowicz, Tauheed Ishrat
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/14/10/983
_version_ 1797513514578870272
author Mohd. Salman
Saifudeen Ismael
Lexiao Li
Heba A. Ahmed
Michelle A. Puchowicz
Tauheed Ishrat
author_facet Mohd. Salman
Saifudeen Ismael
Lexiao Li
Heba A. Ahmed
Michelle A. Puchowicz
Tauheed Ishrat
author_sort Mohd. Salman
collection DOAJ
description We hypothesize that endothelial-specific thioredoxin-interacting protein knock-out (EC-TXNIP KO) mice will be more resistant to the neurovascular damage (hemorrhagic-transformation-HT) associated with hyperglycemia (HG) in embolic stroke. Adult-male EC-TXNIP KO and wild-type (WT) littermate mice were injected with-streptozotocin (40 mg/kg, i.p.) for five consecutive days to induce diabetes. Four-weeks after confirming HG, mice were subjected to embolic middle cerebral artery occlusion (eMCAO) followed by tissue plasminogen activator (tPA)-reperfusion (10 mg/kg at 3 h post-eMCAO). After the neurological assessment, animals were sacrificed at 24 h for neurovascular stroke outcomes. There were no differences in cerebrovascular anatomy between the strains. Infarct size, edema, and HT as indicated by hemoglobin (Hb)-the content was significantly higher in HG-WT mice, with or without tPA-reperfusion, compared to normoglycemic WT mice. Hyperglycemic EC-TXNIP KO mice treated with tPA tended to show lower Hb-content, edema, infarct area, and less hemorrhagic score compared to WT hyperglycemic mice. EC-TXNIP KO mice showed decreased expression of inflammatory mediators, apoptosis-associated proteins, and nitrotyrosine levels. Further, vascular endothelial growth factor-A and matrix-metalloproteinases (MMP-9/MMP-3), which degrade junction proteins and increase blood-brain-barrier permeability, were decreased in EC-TXNIP KO mice. Together, these findings suggest that vascular-TXNIP could be a novel therapeutic target for neurovascular damage after stroke.
first_indexed 2024-03-10T06:17:38Z
format Article
id doaj.art-d411629d00e242999235d876bece756d
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-10T06:17:38Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-d411629d00e242999235d876bece756d2023-11-22T19:35:32ZengMDPI AGPharmaceuticals1424-82472021-09-01141098310.3390/ph14100983Endothelial Thioredoxin-Interacting Protein Depletion Reduces Hemorrhagic Transformation in Hyperglycemic Mice after Embolic Stroke and Thrombolytic TherapyMohd. Salman0Saifudeen Ismael1Lexiao Li2Heba A. Ahmed3Michelle A. Puchowicz4Tauheed Ishrat5Department of Anatomy and Neurobiology, The University of Tennessee Health Science Center, Memphis, TN 38163, USADepartment of Anatomy and Neurobiology, The University of Tennessee Health Science Center, Memphis, TN 38163, USADepartment of Anatomy and Neurobiology, The University of Tennessee Health Science Center, Memphis, TN 38163, USADepartment of Anatomy and Neurobiology, The University of Tennessee Health Science Center, Memphis, TN 38163, USADepartment of Pediatrics, The University of Tennessee Health Science Center, Memphis, TN 38163, USADepartment of Anatomy and Neurobiology, The University of Tennessee Health Science Center, Memphis, TN 38163, USAWe hypothesize that endothelial-specific thioredoxin-interacting protein knock-out (EC-TXNIP KO) mice will be more resistant to the neurovascular damage (hemorrhagic-transformation-HT) associated with hyperglycemia (HG) in embolic stroke. Adult-male EC-TXNIP KO and wild-type (WT) littermate mice were injected with-streptozotocin (40 mg/kg, i.p.) for five consecutive days to induce diabetes. Four-weeks after confirming HG, mice were subjected to embolic middle cerebral artery occlusion (eMCAO) followed by tissue plasminogen activator (tPA)-reperfusion (10 mg/kg at 3 h post-eMCAO). After the neurological assessment, animals were sacrificed at 24 h for neurovascular stroke outcomes. There were no differences in cerebrovascular anatomy between the strains. Infarct size, edema, and HT as indicated by hemoglobin (Hb)-the content was significantly higher in HG-WT mice, with or without tPA-reperfusion, compared to normoglycemic WT mice. Hyperglycemic EC-TXNIP KO mice treated with tPA tended to show lower Hb-content, edema, infarct area, and less hemorrhagic score compared to WT hyperglycemic mice. EC-TXNIP KO mice showed decreased expression of inflammatory mediators, apoptosis-associated proteins, and nitrotyrosine levels. Further, vascular endothelial growth factor-A and matrix-metalloproteinases (MMP-9/MMP-3), which degrade junction proteins and increase blood-brain-barrier permeability, were decreased in EC-TXNIP KO mice. Together, these findings suggest that vascular-TXNIP could be a novel therapeutic target for neurovascular damage after stroke.https://www.mdpi.com/1424-8247/14/10/983hyperglycemiaendothelial-specific TXNIP deletiontissue plasminogen activatorhemorrhagic transformationembolic stroke
spellingShingle Mohd. Salman
Saifudeen Ismael
Lexiao Li
Heba A. Ahmed
Michelle A. Puchowicz
Tauheed Ishrat
Endothelial Thioredoxin-Interacting Protein Depletion Reduces Hemorrhagic Transformation in Hyperglycemic Mice after Embolic Stroke and Thrombolytic Therapy
Pharmaceuticals
hyperglycemia
endothelial-specific TXNIP deletion
tissue plasminogen activator
hemorrhagic transformation
embolic stroke
title Endothelial Thioredoxin-Interacting Protein Depletion Reduces Hemorrhagic Transformation in Hyperglycemic Mice after Embolic Stroke and Thrombolytic Therapy
title_full Endothelial Thioredoxin-Interacting Protein Depletion Reduces Hemorrhagic Transformation in Hyperglycemic Mice after Embolic Stroke and Thrombolytic Therapy
title_fullStr Endothelial Thioredoxin-Interacting Protein Depletion Reduces Hemorrhagic Transformation in Hyperglycemic Mice after Embolic Stroke and Thrombolytic Therapy
title_full_unstemmed Endothelial Thioredoxin-Interacting Protein Depletion Reduces Hemorrhagic Transformation in Hyperglycemic Mice after Embolic Stroke and Thrombolytic Therapy
title_short Endothelial Thioredoxin-Interacting Protein Depletion Reduces Hemorrhagic Transformation in Hyperglycemic Mice after Embolic Stroke and Thrombolytic Therapy
title_sort endothelial thioredoxin interacting protein depletion reduces hemorrhagic transformation in hyperglycemic mice after embolic stroke and thrombolytic therapy
topic hyperglycemia
endothelial-specific TXNIP deletion
tissue plasminogen activator
hemorrhagic transformation
embolic stroke
url https://www.mdpi.com/1424-8247/14/10/983
work_keys_str_mv AT mohdsalman endothelialthioredoxininteractingproteindepletionreduceshemorrhagictransformationinhyperglycemicmiceafterembolicstrokeandthrombolytictherapy
AT saifudeenismael endothelialthioredoxininteractingproteindepletionreduceshemorrhagictransformationinhyperglycemicmiceafterembolicstrokeandthrombolytictherapy
AT lexiaoli endothelialthioredoxininteractingproteindepletionreduceshemorrhagictransformationinhyperglycemicmiceafterembolicstrokeandthrombolytictherapy
AT hebaaahmed endothelialthioredoxininteractingproteindepletionreduceshemorrhagictransformationinhyperglycemicmiceafterembolicstrokeandthrombolytictherapy
AT michelleapuchowicz endothelialthioredoxininteractingproteindepletionreduceshemorrhagictransformationinhyperglycemicmiceafterembolicstrokeandthrombolytictherapy
AT tauheedishrat endothelialthioredoxininteractingproteindepletionreduceshemorrhagictransformationinhyperglycemicmiceafterembolicstrokeandthrombolytictherapy